Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec;29(12):1726-1735.
doi: 10.1007/s10995-025-04182-8. Epub 2025 Oct 14.

Patterns of Non-fatal Overdose and Injection-Related Bacterial Infections During Pregnancy and the Postpartum Year Among New York State Residents

Hannah L F Cooper  1 , Rohan R D'Souza  2 , Howard H Chang  2 , Emily Peterson  2 , Erin Rogers  2 , Simone Wien  2 , Sarah C Blake  2 , Michael R Kramer  2
Affiliations

Patterns of Non-fatal Overdose and Injection-Related Bacterial Infections During Pregnancy and the Postpartum Year Among New York State Residents

Hannah L F Cooper et al. Matern Child Health J. 2025 Dec.

Abstract

Objectives: Overdoses are a leading cause of maternal mortality in the US, but limited evidence exists about patterns of nonfatal overdose, a key risk factor for subsequent fatal overdose, or of other drug-related harms. Here, we estimate prevalences of nonfatal overdose and injection-related endocarditis and abscesses/cellulitis across the 21 months spanning pregnancy and the postpartum year.

Methods: Among people who experienced an in-hospital birth in New York State between 9/1/2016 and 1/1/2018 (N = 330,872), we estimated the prevalences of hospital-based diagnoses of nonfatal overdose and of injection-related bacterial infections (i.e., endocarditis, abscesses, and cellulitis) across these 21 months; by trimester and postpartum quarter; and by social position (e.g., race/ethnicity, rurality, payor).

Results: The 21-month nonfatal overdose prevalence was 158/100,000 births (CI: 145/100,000, 172/100,000); the 21-month prevalence of injection-related bacterial infections was 56/100,000 births (CI: 49/100,000, 65/100,000). There was a trend such that rates of overdose and of injection-related bacterial infections declined as pregnancy progressed and rebounded postpartum. Rates of all outcomes were highest outside of large metropolitan areas and among publicly insured residents.

Conclusions for practice: The trend toward diminished rates during pregnancy is supported by past qualitative studies. If confirmed by future research in other geographical regions and with larger sample sizes, this finding holds promise for programmatic and policy interventions. Interventions co-designed with people who use drugs could complement and support harm reduction efforts that pregnant people are already engaging in independently. Such efforts can help people who use drugs survive the pregnancy and postpartum year.

Keywords: Abscess; Endocarditis; Maternal; Overdose; Postpartum; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: We have no conflicts to disclose. Ethical Approval: The Emory Institutional Review Board approved all analyses. Consent to Participate: N/A. Analysis of existing hospital discharge data. Consent for Publication: N/A. Analysis of existing hospital discharge data.

Update of

References

    1. Alkhouli, M., Alqahtani, F., Alhajji, M., Berzingi, C. O., & Sohail, M. R. (2020). Clinical and economic burden of hospitalizations for infective endocarditis in the United States. In: Mayo Clinic Proceedings: 95(5) 858-866 . - PubMed
    1. Amiri, S., McDonell, M. G., Denney, J. T., Buchwald, D., & Amram, O. (2021). Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: A US nationwide small area analysis. Value in Health,24(2), 188–195. - DOI - PubMed
    1. Asher, A. K., Zhong, Y., Garfein, R. S., Cuevas-Mota, J., & Teshale, E. (2019). Association of self-reported abscess with high-risk injection-related behaviors among young persons who inject drugs. Journal of the Association of Nurses in AIDS Care,30(2), 142–150. - DOI - PMC - PubMed
    1. Bai, A. D., Komorowski, A. S., Lo, C. K., Tandon, P., Li, X. X., Mokashi, V., Cvetkovic, A., Findlater, A., Liang, L., & Tomlinson, G. (2021). Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials. Trials,22, 1–10. - DOI - PMC - PubMed
    1. Ball, L. J., Sherazi, A., Laczko, D., Gupta, K., Koivu, S., Weir, M. A., Mele, T., Tirona, R., McCormick, J. K., & Silverman, M. (2018). Validation of an algorithm to identify infective endocarditis in people who inject drugs. Medical Care,56(10), e70–e75. - DOI - PubMed